Caryophyllene is the only cannabis terpene that binds directly to CB2 cannabinoid receptors — the receptors most-involved in inflammation and peripheral pain sensation. That means it works alongside the cannabinoids, not just as an aroma. The clinical evidence for pain is stronger for caryophyllene than for any other single terpene.

Look for strains where caryophyllene is the dominant note, with myrcene or humulene as supporting terpenes. That combination is the workhorse profile for chronic pain in our catalog.

For joint, muscle, or skin-localized pain, a CBD topical is often a better first choice than smoking flower. Topicals act locally without psychoactive effects — useful for daytime application or for people who can't be impaired (driving, working). Most CBD topicals don't cross meaningfully into the bloodstream.

We carry CBD balms specifically for this. Pair them with smoke/vape THCa at night if your pain has both a daytime-localized and an evening-systemic component.

Cannabis for pain works for some users and not others. The clinical evidence is strongest for: chronic neuropathic pain, chemotherapy-related pain, multiple-sclerosis-related spasticity. Less strong for: acute injury pain, post-surgical pain, fibromyalgia (mixed evidence).

If you're using cannabis to reduce opioid dependence: start by adding cannabis to your existing regimen, not replacing it cold-turkey. Talk to your prescriber. There's a documented "opioid-sparing" effect (cannabis users need less opioid for equivalent relief) but it's not a one-for-one substitute.